BTG2 and cancer: More importantly, knockdown of BTG2 counteracted the inhibiting impact that miR-92a-3p inhibitors had on the malignant biological behaviors of BC cells, while overexpression of BTG2 partially attenuated the cancer-promoting effect of miR-92a-3p in BC.